EyePoint Pharmaceuticals, Inc. (EYPT) CEO Nancy Lurker on Q3 2021 Results – Earnings Call Transcript

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q3 2021 Earnings Conference Call November 3, 2021 8:30 AM ET
Company Participants
George O. Elston – CFO & Head, Corporate Development
Nancy Lurker – President & CEO
Jay Duker – COO
Scott Jones – Chief Commercial…

Click here to view the original article.